SlideShare uma empresa Scribd logo
1 de 24
Introduction to Pharmacology
Name : Yukta Wankhede
Programme : MSc MT Cardiac Care Technology
Content
Principle of Drug Action
• The Drug administration
• The Pharmacokinetic phase
• The Pharmacodynamic phase
Administration of Drugs
• Enteral
• Parenteral
Principle of Drug Action : The Drug Administration
• Most of the drug can be administered by different routes. Drug
and patient-related factors determine the selection of routes for
drug administration.
• These factors are :
a. Characteristics of the drug
b. Emergency / routine use
c. Condition of the patient (unconsious, vomiting & diarrhoea)
d. Age of the patient
e. Associated diseases
The Drug Administration
Pharmacokinetics
• Definition
Pharmacokinetics id derived from 2 words:
Pharmaco meaning drug and Kinesis meaning movement.
In short , it is what the body does to the drug.
It includes Absorption (A), Distribution (D), Metabolism (M)
and Excretion (E).
Pharmacokinetics
Pharmacokinetics as a drug’s journey through
the body, during which it passes through four
different phases: absorption, distribution,
metabolism, and excretion (ADME). The four
steps are:
• Absorption: Describes how the drug moves
from the site of administration to the site of
action.
• Distribution: Describes the journey of the drug
through the bloodstream to various tissues of
the body.
• Metabolism: Describes the process that
breaks down the drug.
• Excretion: Describes the removal of the drug
from the body.
Pharmacokinetics
Absorption
• Absorption is the movement of a drug from its site of administration
to the bloodstream. The rate and extent of drug absorption depend
on multiple factors, such as:
• Route of administration
• The formulation and chemical properties of a drug
• Drug-food interactions
• The administration (e.g., oral, intravenous, inhalation) of a drug
influences bioavailability, the fraction of the active form of a drug that
enters the bloodstream and successfully reaches its target site.
• When a drug is given intravenously, absorption is not required, and
bioavailability is 100% because the active form of the medicine is
delivered immediately to the systemic circulation. However, orally
administered medications have incomplete absorption and result in
less drug delivery to the site of action. For example, many orally
administered drugs are metabolized within the gut wall or the liver
before reaching the systemic circulation. This is referred to as first-
pass metabolism, which reduces drug absorption.
Pharmacokinetics
Distribution
• The process of drug distribution is important because it can affect
how much drug ends up in the active sites, and thus drug efficacy
and toxicity. A drug will move from the absorption site to tissues
around the body, such as brain tissue, fat, and muscle. Many factors
could influence this, such as blood flow, lipophilicity, molecular size,
and how the drug interacts with the components of blood, like
plasma proteins.
• For example, a drug like warfarin is highly protein-bound, which
means only a small percentage of the drug is free in the bloodstream
to exert its therapeutic effects. If a highly protein-bound drug is given
in combination with warfarin, it could displace warfarin from the
protein-binding site and increase the amount that enters the
bloodstream.
• Additionally, there are anatomical barriers found in certain organs
like the blood-brain barrier, preventing certain drugs from going into
brain tissue. Drugs with certain characteristics, like high lipophilicity,
small size, and molecular weight will be better able to cross the
blood brain barrier.
Pharmacokinetics
Metabolism
• Cytochrome enzymes (CYP450) are responsible for the biotransformation or
metabolism of about 70-80% of all drugs in clinical use.
What are some factors that affect drug metabolism?
• Genetics can impact whether someone metabolizes drugs more quickly or
slowly.
• Age can impact liver function; the elderly have reduced liver function and
may metabolize drugs more slowly, increasing risk of intolerability, and
newborns or infants have immature liver function and may require special
dosing considerations.
• Drug interactions can lead to decreased drug metabolism by enzyme
inhibition or increased drug metabolism by enzyme induction.
Pharmacokinetics
Metabolism
• Cytochrome enzymes (CYP450) are responsible for the biotransformation or metabolism of about 70-80% of all drugs in
clinical use.
• When a drug is metabolized through CYP450 enzymes, it results in inactive metabolites, which have none of the original
drug's pharmacologic activity. However, certain medications, like codeine, are inactive and become converted in the body
into a pharmacologically active drug. These are commonly referred to as prodrugs.
• As you can imagine, having genetic variations in CYP2D6, the metabolic pathway for codeine, can have significant clinical
consequences. Usually, CYP2D6 poor metabolizers (PMs) have higher serum levels of active drugs. In codeine, PMs have
higher serum levels of the inactive drug, which could result in inefficacy. Conversely, ultra-rapid metabolizers (UMs) will
transform codeine to morphine extremely quickly, resulting in toxic morphine levels.
• The FDA added a black box warning to the codeine drug label, stating that respiratory depression and death have occurred
in children who received codeine following a tonsillectomy and/or adenoidectomy and who have evidence of being a
CYP2D6 UM.
Pharmacokinetics
Excretion
• Elimination involves both the metabolism and the excretion of the
drug through the kidneys, and to a much smaller degree, into the
bile.
• Excretion into the urine through the kidneys is one of the most
important mechanisms of drug removal.
• Many factors affect excretion, such as:
• Direct renal dysfunction, which could prolong the half-life of certain
drugs and necessitate dose adjustments.
• Age, which can contribute to differing rates of excretion and impact
dosing of medications.
• Pathologies that impact renal blood flow, such as congestive heart
failure and liver disease can make drug excretion less efficient
• Whether it’s a patient who just had gastric bypass surgery, a
CYP2D6 poor metabolizer, or a patient with renal dysfunction, an
individual’s characteristics affect these four processes, which can
ultimately influence medication selection.
• Pharmacodynamics is the aspects relating to ‘what the
drug does to the body’.
• It is the study of drugs – their mechanism of action ,
pharmacological actions and adverse effect.
Pharmacodynamics
Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.
Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.
Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.

Mais conteúdo relacionado

Mais procurados

Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
mizan00
 
[Pharma] routes of drug administration
[Pharma] routes of drug administration[Pharma] routes of drug administration
[Pharma] routes of drug administration
Muhammad Ahmad
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
Md. Jakiul Islam
 

Mais procurados (20)

Routes of administrations
Routes of administrationsRoutes of administrations
Routes of administrations
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
5.routes of drug administration
5.routes of drug administration5.routes of drug administration
5.routes of drug administration
 
2 routes of administration
2 routes of administration2 routes of administration
2 routes of administration
 
Drug adminstration routes
Drug adminstration routesDrug adminstration routes
Drug adminstration routes
 
[Pharma] routes of drug administration
[Pharma] routes of drug administration[Pharma] routes of drug administration
[Pharma] routes of drug administration
 
Routes of administration
Routes of administrationRoutes of administration
Routes of administration
 
Routes of administration of drug
Routes of administration of drugRoutes of administration of drug
Routes of administration of drug
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
7. Routes Of Drug Administration
7. Routes Of Drug Administration7. Routes Of Drug Administration
7. Routes Of Drug Administration
 
Routes of Drug administration - Pharmacology
Routes of Drug administration - PharmacologyRoutes of Drug administration - Pharmacology
Routes of Drug administration - Pharmacology
 
Route of administration of drugs
Route of administration of drugsRoute of administration of drugs
Route of administration of drugs
 
routes of drug adminstration
routes of drug adminstrationroutes of drug adminstration
routes of drug adminstration
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
Route of drug administration
Route of drug administrationRoute of drug administration
Route of drug administration
 
Route of Drug Administaration
Route of Drug AdministarationRoute of Drug Administaration
Route of Drug Administaration
 
Routes of administration...pharmacology
Routes of administration...pharmacologyRoutes of administration...pharmacology
Routes of administration...pharmacology
 
Routes of drug administration
Routes of drug administrationRoutes of drug administration
Routes of drug administration
 
parenteral route of drug administration
parenteral route of drug administrationparenteral route of drug administration
parenteral route of drug administration
 
Sanjib
SanjibSanjib
Sanjib
 

Semelhante a Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.

Semelhante a Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics. (20)

Therapuetic drug monitoring
Therapuetic drug monitoringTherapuetic drug monitoring
Therapuetic drug monitoring
 
Toxicology
ToxicologyToxicology
Toxicology
 
DRUG ACTION- NURSING FOUNDATIONS.pptx
DRUG ACTION- NURSING FOUNDATIONS.pptxDRUG ACTION- NURSING FOUNDATIONS.pptx
DRUG ACTION- NURSING FOUNDATIONS.pptx
 
2 - DRUG METABOLISM 2023.pptx
2 -  DRUG METABOLISM 2023.pptx2 -  DRUG METABOLISM 2023.pptx
2 - DRUG METABOLISM 2023.pptx
 
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
understanding-the-fundamental-principles-of-biopharmaceutics-pharmacokinetics...
 
Pharmacology for rehablitition nursing in geriartic
Pharmacology for rehablitition nursing in geriarticPharmacology for rehablitition nursing in geriartic
Pharmacology for rehablitition nursing in geriartic
 
Pharmacology part 2
Pharmacology part 2Pharmacology part 2
Pharmacology part 2
 
Introduction to pharmacology
Introduction to pharmacologyIntroduction to pharmacology
Introduction to pharmacology
 
Pharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adultsPharmacotherapy considerations in elderly adults
Pharmacotherapy considerations in elderly adults
 
Toxicokinetics toxicology pre-clinical pharmacology
Toxicokinetics  toxicology  pre-clinical pharmacologyToxicokinetics  toxicology  pre-clinical pharmacology
Toxicokinetics toxicology pre-clinical pharmacology
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
1 Pharmacology Pharmacokinetics
1 Pharmacology   Pharmacokinetics1 Pharmacology   Pharmacokinetics
1 Pharmacology Pharmacokinetics
 
General Pharmacology for Physiotherapists
General Pharmacology for PhysiotherapistsGeneral Pharmacology for Physiotherapists
General Pharmacology for Physiotherapists
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptx
 
PKPD NEW.pptx
PKPD NEW.pptxPKPD NEW.pptx
PKPD NEW.pptx
 
SESSION 1 PHARMA.pptx at ghhhjjyggggghhh
SESSION 1 PHARMA.pptx at ghhhjjyggggghhhSESSION 1 PHARMA.pptx at ghhhjjyggggghhh
SESSION 1 PHARMA.pptx at ghhhjjyggggghhh
 
PHARMACOKINETIC
PHARMACOKINETICPHARMACOKINETIC
PHARMACOKINETIC
 
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...introduction in clinical pharmacology. Main principles of clinical pharmacolo...
introduction in clinical pharmacology. Main principles of clinical pharmacolo...
 
General pharmacology intro
General pharmacology introGeneral pharmacology intro
General pharmacology intro
 
General pharmacology intro
General pharmacology introGeneral pharmacology intro
General pharmacology intro
 

Mais de Yukta Wankhede

Mais de Yukta Wankhede (8)

VenoArterila ECMO - 006.pptx
VenoArterila ECMO - 006.pptxVenoArterila ECMO - 006.pptx
VenoArterila ECMO - 006.pptx
 
HEART FAILURE.pptx
HEART FAILURE.pptxHEART FAILURE.pptx
HEART FAILURE.pptx
 
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
Severe Aortic Stenosis with Ischemic Heart Disease. (Management of TAVI) - Pa...
 
FETAL ECHOCARDIOGRAPHY-006.pptx
FETAL ECHOCARDIOGRAPHY-006.pptxFETAL ECHOCARDIOGRAPHY-006.pptx
FETAL ECHOCARDIOGRAPHY-006.pptx
 
Development of Heart (Embryology)
Development of Heart (Embryology)Development of Heart (Embryology)
Development of Heart (Embryology)
 
Bundle Branch Block
Bundle Branch BlockBundle Branch Block
Bundle Branch Block
 
Left ventricular diastolic dysfunction in echocardiography
Left ventricular diastolic dysfunction in echocardiographyLeft ventricular diastolic dysfunction in echocardiography
Left ventricular diastolic dysfunction in echocardiography
 
Drug and electrolytes effect on ECG
Drug and electrolytes effect on ECGDrug and electrolytes effect on ECG
Drug and electrolytes effect on ECG
 

Último

Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 

Último (20)

Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-IIFood Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
Food Chain and Food Web (Ecosystem) EVS, B. Pharmacy 1st Year, Sem-II
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
psychiatric nursing HISTORY COLLECTION .docx
psychiatric  nursing HISTORY  COLLECTION  .docxpsychiatric  nursing HISTORY  COLLECTION  .docx
psychiatric nursing HISTORY COLLECTION .docx
 

Introduction to pharmacology, Route of Drug Administration , Pharmacokinetics and Pharmacodynamics.

  • 1. Introduction to Pharmacology Name : Yukta Wankhede Programme : MSc MT Cardiac Care Technology
  • 2. Content Principle of Drug Action • The Drug administration • The Pharmacokinetic phase • The Pharmacodynamic phase Administration of Drugs • Enteral • Parenteral
  • 3. Principle of Drug Action : The Drug Administration • Most of the drug can be administered by different routes. Drug and patient-related factors determine the selection of routes for drug administration. • These factors are : a. Characteristics of the drug b. Emergency / routine use c. Condition of the patient (unconsious, vomiting & diarrhoea) d. Age of the patient e. Associated diseases
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Pharmacokinetics • Definition Pharmacokinetics id derived from 2 words: Pharmaco meaning drug and Kinesis meaning movement. In short , it is what the body does to the drug. It includes Absorption (A), Distribution (D), Metabolism (M) and Excretion (E).
  • 14. Pharmacokinetics Pharmacokinetics as a drug’s journey through the body, during which it passes through four different phases: absorption, distribution, metabolism, and excretion (ADME). The four steps are: • Absorption: Describes how the drug moves from the site of administration to the site of action. • Distribution: Describes the journey of the drug through the bloodstream to various tissues of the body. • Metabolism: Describes the process that breaks down the drug. • Excretion: Describes the removal of the drug from the body.
  • 15. Pharmacokinetics Absorption • Absorption is the movement of a drug from its site of administration to the bloodstream. The rate and extent of drug absorption depend on multiple factors, such as: • Route of administration • The formulation and chemical properties of a drug • Drug-food interactions • The administration (e.g., oral, intravenous, inhalation) of a drug influences bioavailability, the fraction of the active form of a drug that enters the bloodstream and successfully reaches its target site. • When a drug is given intravenously, absorption is not required, and bioavailability is 100% because the active form of the medicine is delivered immediately to the systemic circulation. However, orally administered medications have incomplete absorption and result in less drug delivery to the site of action. For example, many orally administered drugs are metabolized within the gut wall or the liver before reaching the systemic circulation. This is referred to as first- pass metabolism, which reduces drug absorption.
  • 16. Pharmacokinetics Distribution • The process of drug distribution is important because it can affect how much drug ends up in the active sites, and thus drug efficacy and toxicity. A drug will move from the absorption site to tissues around the body, such as brain tissue, fat, and muscle. Many factors could influence this, such as blood flow, lipophilicity, molecular size, and how the drug interacts with the components of blood, like plasma proteins. • For example, a drug like warfarin is highly protein-bound, which means only a small percentage of the drug is free in the bloodstream to exert its therapeutic effects. If a highly protein-bound drug is given in combination with warfarin, it could displace warfarin from the protein-binding site and increase the amount that enters the bloodstream. • Additionally, there are anatomical barriers found in certain organs like the blood-brain barrier, preventing certain drugs from going into brain tissue. Drugs with certain characteristics, like high lipophilicity, small size, and molecular weight will be better able to cross the blood brain barrier.
  • 17. Pharmacokinetics Metabolism • Cytochrome enzymes (CYP450) are responsible for the biotransformation or metabolism of about 70-80% of all drugs in clinical use. What are some factors that affect drug metabolism? • Genetics can impact whether someone metabolizes drugs more quickly or slowly. • Age can impact liver function; the elderly have reduced liver function and may metabolize drugs more slowly, increasing risk of intolerability, and newborns or infants have immature liver function and may require special dosing considerations. • Drug interactions can lead to decreased drug metabolism by enzyme inhibition or increased drug metabolism by enzyme induction.
  • 18. Pharmacokinetics Metabolism • Cytochrome enzymes (CYP450) are responsible for the biotransformation or metabolism of about 70-80% of all drugs in clinical use. • When a drug is metabolized through CYP450 enzymes, it results in inactive metabolites, which have none of the original drug's pharmacologic activity. However, certain medications, like codeine, are inactive and become converted in the body into a pharmacologically active drug. These are commonly referred to as prodrugs. • As you can imagine, having genetic variations in CYP2D6, the metabolic pathway for codeine, can have significant clinical consequences. Usually, CYP2D6 poor metabolizers (PMs) have higher serum levels of active drugs. In codeine, PMs have higher serum levels of the inactive drug, which could result in inefficacy. Conversely, ultra-rapid metabolizers (UMs) will transform codeine to morphine extremely quickly, resulting in toxic morphine levels. • The FDA added a black box warning to the codeine drug label, stating that respiratory depression and death have occurred in children who received codeine following a tonsillectomy and/or adenoidectomy and who have evidence of being a CYP2D6 UM.
  • 19. Pharmacokinetics Excretion • Elimination involves both the metabolism and the excretion of the drug through the kidneys, and to a much smaller degree, into the bile. • Excretion into the urine through the kidneys is one of the most important mechanisms of drug removal. • Many factors affect excretion, such as: • Direct renal dysfunction, which could prolong the half-life of certain drugs and necessitate dose adjustments. • Age, which can contribute to differing rates of excretion and impact dosing of medications. • Pathologies that impact renal blood flow, such as congestive heart failure and liver disease can make drug excretion less efficient • Whether it’s a patient who just had gastric bypass surgery, a CYP2D6 poor metabolizer, or a patient with renal dysfunction, an individual’s characteristics affect these four processes, which can ultimately influence medication selection.
  • 20.
  • 21. • Pharmacodynamics is the aspects relating to ‘what the drug does to the body’. • It is the study of drugs – their mechanism of action , pharmacological actions and adverse effect. Pharmacodynamics